26th Anniversary Celebration Series: Inauguration Ceremony of the Artificial Intelligence Cross Disciplinary Research Institute and Anniversary Academic Lecture 1 Honorary Doctor Krzysztof PALCZEWSKI to Speak at MUST on 「Precision Gene Editing: Rewriting the Code of Life」
26th Anniversary Celebration Series:
Inauguration Ceremony of the Artificial Intelligence Cross Disciplinary Research Institute and Anniversary Academic Lecture 1
Honorary Doctor Krzysztof PALCZEWSKI to Speak at MUST on
「Precision Gene Editing: Rewriting the Code of Life」
Date: 26 March 2026 (Thursday)
Time: 10:00–11:30
Venue: N101 Hall, Macau University of Science and Technology
Topic: Precision Gene Editing: Rewriting the Code of Life
Distinguished Guest Speaker: Academician Krzysztof PALCZEWSKI — Member of the U.S. National Academy of Sciences, Member of the U.S. National Academy of Medicine, Foreign Member of the Polish Academy of Arts and Sciences, biochemist and pharmacologist, and 2026 Honorary Doctor of MUST

Organized by Macau University of Science and Technology, 26th Anniversary Celebration Series: Inauguration Ceremony of the Artificial Intelligence Cross Disciplinary Research Institute and Anniversary Academic Lecture 1, will be held at 10:00 a.m. on Thursday, 26 March 2026, at N101 Hall.
The inauguration ceremony will mark the establishment of the Artificial Intelligence Cross Disciplinary Research Institute (AI-X). The Institute is dedicated to integrating the University’s strengths in artificial intelligence, biomedicine, clinical translation, and big data analytics, with the aim of building a cross-disciplinary collaborative innovation platform and advancing basic research, technology development, technology transfer, and international collaboration. The Institute has already completed the initial formation of its core academic team and is concurrently planning postgraduate recruitment and a series of academic activities, marking a new stage in the University’s development in artificial intelligence cross-disciplinary applications.
The lecture will be delivered by Academician Krzysztof PALCZEWSKI, a member of the U.S. National Academy of Sciences and the U.S. National Academy of Medicine, a foreign member of the Polish Academy of Arts and Sciences, a biochemist and pharmacologist, and a 2026 Honorary Doctor of MUST. In his lecture, “Precision Gene Editing: Rewriting the Code of Life,” he will share cutting-edge academic insights with the audience. The lecture will highlight the therapeutic potential of gene augmentation and CRISPR/Cas9-based precise genome editing for inherited retinal disorders, including strategies to deliver a normal gene copy or directly correct disease-causing mutations. It will also introduce how artificial intelligence can support high-throughput genetic analysis, guide RNA prediction, Cas variant optimization, and ocular delivery design, with the aim of improving editing precision, safety, and long-term efficacy.
Dr. PALCZEWSKI is an internationally renowned biochemist and pharmacologist. He currently serves as the Irving H. Leopold Chair of Ophthalmology at the University of California, Irvine, and founded the Center for Translational Vision Research. He is widely recognized as one of the world’s leading vision scientists. His long-standing contributions to vision science include pioneering work on the retinal visual cycle and the molecular mechanisms of retinal diseases. His representative achievements include ground-breaking research on G protein coupled receptor (GPCR), the determination of the crystal structure of the world’s first GPCR (rhodopsin), structural studies of RPE65, a key enzyme in the visual cycle, and major advances in understanding and developing therapeutic strategies for blinding eye diseases. His work has bridged basic science and clinical translation, exerting a profound influence on both the understanding of visual mechanisms and the development of treatments for eye diseases.
Registration & Contact
Open to the public. For inquiries or registration, please contact:
Tel: +853 8897 3568
Email: [email protected]